We are live on ! Find out more
CLB icon

Core Laboratories

Positive
Neutral
Negative
Sentiment 3-Months
Positive 10%
Neutral 40%
Negative 50%

Neutral
PRNewsWire
14 days ago
CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, June 30, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter 2026 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m.
CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
Negative
Zacks Investment Research
1 month ago
Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?
CLB faces persistent geopolitical uncertainty, weaker laboratory activity, cost inflation and delayed shipments, limiting visibility into a stronger recovery.
Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?
Negative
Zacks Investment Research
1 month ago
Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?
Neutral
Zacks Investment Research
1 month ago
Implied Volatility Surging for Core Laboratories Stock Options
Investors need to pay close attention to CLB stock based on the movements in the options market lately.
Implied Volatility Surging for Core Laboratories Stock Options
Negative
Zacks Investment Research
2 months ago
Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y
CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y
Neutral
Seeking Alpha
2 months ago
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
Neutral
PRNewsWire
2 months ago
CORE LAB REPORTS FIRST QUARTER 2026 RESULTS
REVENUE OF $121.8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAR OPERATING INCOME OF $1.9 MILLION; EX-ITEMS, $6.6 MILLION, DOWN 58% SEQUENTIALLY AND 44% YEAR-OVER-YEAR GAAP LOSS PER SHARE OF $0.02 ; EPS EX-ITEMS OF $0.06, DOWN 72% SEQUENTIALLY AND 58% YEAR-OVER-YEAR FREE CASH FLOW OF $0.5 MILLION NET DEBT INCREASED BY $3.9 MILLION; LEVERAGE RATIO AT 1.20 COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR $0.9 MILLION AGGREGATE PURCHASE PRICE COMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDEND HOUSTON, April 29, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported first quarter 2026 revenue of $121,800,000. Core's operating income was $1,900,000, with a loss per diluted share of $0.02, all in accordance with U.S. generally accepted accounting principles ("GAAP").
CORE LAB REPORTS FIRST QUARTER 2026 RESULTS
Positive
Zacks Investment Research
2 months ago
DTI or CLB: Which Is the Better Value Stock Right Now?
Investors interested in Oil and Gas - Field Services stocks are likely familiar with Drilling Tools International Corp. (DTI) and Core Laboratories (CLB). But which of these two stocks presents investors with the better value opportunity right now?
DTI or CLB: Which Is the Better Value Stock Right Now?
Negative
Zacks Investment Research
2 months ago
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
CLB heads into Q1 earnings with lowered guidance, geopolitical disruptions and cost pressures raising concerns over a potential earnings miss.
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
Negative
Zacks Investment Research
2 months ago
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline